NCT00797992View on ClinicalTrials.gov

Bevacizumab Intravitreal for Myopic Choroidal Neovascularization

PHASE4CompletedINTERVENTIONAL
Enrollment

5

Participants

Timeline

Start Date

January 31, 2007

Primary Completion Date

November 30, 2008

Study Completion Date

November 30, 2008

Conditions
Myopic Choroidal Neovascularization
Interventions
DRUG

Injection

Intravitreal injection of 1.25 mg bevacizumab

Trial Locations (1)

74120-050

Instituto de Olhos de Goiania, Goiânia

All Listed Sponsors
lead

Instituto de Olhos de Goiania

OTHER

NCT00797992 - Bevacizumab Intravitreal for Myopic Choroidal Neovascularization | Biotech Hunter | Biotech Hunter